Berkeley Capital Partners, LLC - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 624 filers reported holding VANECK VECTORS ETF TR in Q2 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.

Quarter-by-quarter ownership
Berkeley Capital Partners, LLC ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2023$3,787,312
-8.4%
140,740
+2.5%
1.37%
-6.6%
Q2 2023$4,134,540
-8.4%
137,314
-1.6%
1.46%
-12.5%
Q1 2023$4,515,717
+12.0%
139,589
-0.8%
1.67%
+7.2%
Q4 2022$4,033,219
+18.1%
140,726
-0.6%
1.56%
+5.6%
Q3 2022$3,414,000
-14.4%
141,557
-2.8%
1.48%
-10.3%
Q2 2022$3,989,000
-37.3%
145,705
-12.2%
1.65%
-35.1%
Q1 2022$6,366,000
+195.4%
165,989
+146.8%
2.54%
+186.7%
Q4 2021$2,155,000
-77.3%
67,269
-79.1%
0.88%
-79.7%
Q3 2021$9,481,000
-28.9%
321,724
-18.0%
4.36%
-26.5%
Q2 2021$13,330,000
+5.9%
392,286
+1.3%
5.94%
-2.2%
Q1 2021$12,588,000
+36.9%
387,327
+51.7%
6.07%
+28.6%
Q4 2020$9,197,000
+671.6%
255,334
+738.6%
4.72%
+549.4%
Q3 2020$1,192,000
+30.4%
30,446
+22.2%
0.73%
+29.1%
Q2 2020$914,000
+77.1%
24,923
+11.4%
0.56%
+60.4%
Q1 2020$516,000
-79.3%
22,382
-73.7%
0.35%
-72.5%
Q4 2019$2,495,000
+12.9%
85,207
+3.0%
1.28%
+9.6%
Q3 2019$2,210,00082,7421.17%
Other shareholders
VANECK VECTORS ETF TR shareholders Q2 2020
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$20,220,00066.82%
Baymount Management LP 145,000$3,970,00028.08%
New Harbor Financial Group, LLC 1,371,341$37,547,00018.51%
New Harbor Financial Group, LLC 1,291,700$35,366,00017.44%
MKP Capital Management, L.L.C. 1,500,000$41,070,00013.74%
Windmill Hill Asset Management Ltd 844,600$23,125,00011.94%
Hollow Brook Wealth Management LLC 768,567$21,043,00011.57%
Grand Central Investment Group 261,915$7,171,00010.33%
Point72 Europe (London) LLP 1,467,000$40,166,0008.50%
Slate Path Capital LP 4,600,000$125,948,0007.87%
View complete list of VANECK VECTORS ETF TR shareholders